Abstracts Archive - Page 359 of 1683 - ATC Abstracts

2020 American Transplant Congress
Treatment of De Novo Renal Transplant Recipients with Calcineurin Inhibitor (CNI)-Free, Belatacept+Everolimus-Based Immunosuppression
V. R. Peddi¹, B. Marder², L. Gaite³, J. Oberholzer⁴, R. Goldberg⁵, T. Pearson⁶, H. Yang⁷, L. Allamassey⁸, S. Gao⁸, M. Polinsky⁸, R. N. Formica⁹
¹California Pacific Medical Center, San Francisco, CA, ²Colorado Kidney Care, Denver, CO, ³Hospital Marqués de Valdecilla, Cantabria, Spain, ⁴UVA Health, Charlottesville, VA, ⁵Saint Barnabas Medical Center, Livingston, NJ, ⁶Emory University School of Medicine, Atlanta, GA, ⁷UPMC Pinnacle, Harrisburg, PA, ⁸Bristol-Myers Squibb, Princeton, NJ, ⁹Yale University School of Medicine, New Haven, CT
*Purpose: Compared with CNI-based immunosuppression, kidney transplant recipients receiving belatacept-based treatment present with a favorable metabolic profile, reduced chronic allograft nephropathy, and improved renal function,…
2020 American Transplant Congress
Cumulative United States Experience with Domino Liver Transplants
A. Gruessner, J. Renz, S. Saggi, R. Gruessner
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: The ongoing shortage of livers in the setting of growing waiting lists remains a challenge in transplantation. First introduced in 1996, domino liver transplantation…
2020 American Transplant Congress
Progression of Insulin Resistance after Liver Transplantation – Prospective Study
I. Mikova¹, D. Erhartova¹, K. Dvorakova¹, P. Sedivy², M. Drobny², M. Dezortova², M. Hajek², M. Cahová³, H. Dankova³, E. Sticova⁴, V. Lanska⁵, P. Trunecka¹
¹Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, ²Radiodiagnostic and Interventional Radiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, ³Experimental Medicine Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, ⁴Department of Clinical and Transplant Pathology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, ⁵Medical Statistics Unit, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
*Purpose: Insulin resistance (IR) plays an important role in pathogenesis of nonalcoholic fatty liver disease (NAFLD) and other diseases. The data about prevalence and evolution…
2020 American Transplant Congress
The Centennial Allograft – Can an Organ Function for Over 100 Years in 2 Different Individuals?
A. Gruessner, J. Renz, S. Saggi, R. Gruessner
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: We investigated the occurrence of deceased-donor liver (DDOLT), deceased-donor renal (DDRT), and living-donor renal allografts (LDRT) that have achieved or come close to 100…
2020 American Transplant Congress
IM Naltrexone Post Liver Transplant for Alcoholic Hepatitis Patients to Prevent Relapse
A. Flecha
Transplant Surgery, Montefiore Medical Center, Bronx, NY
*Purpose: The number of patients requiring liver transplants due to Hepatitis C Virus is declining due to the new treatment options, and the growing number…
2020 American Transplant Congress
Rates of Live Donor Liver Transplantation Vary by Socioeconomic Status and Geography
D. R. Jorgensen, A. Humar, C. Hughes, M. Molinari, A. Ganoza, S. Ganesh, A. Duarte-Rojo, A. Tevar
Surgery, University of Pittsburgh, Pittsburgh, PA
*Purpose: Live donor liver transplantation (LDT) carries with it many benefits for the recipient, including reduced time on waitlist, transplantation at a lower meld score,…
2020 American Transplant Congress
Correlation of CMV and EBV DNAemia in the Development of Invasive Fungal Disease among Pediatric Intestinal and Liver Transplant Recipients
B. M. Chatani¹, J. Garcia², T. Beduschi³, A. Tekin³, R. Vianna³, I. A. Gonzalez¹
¹Pediatric Infectious Disease, University of Miami Miller School of Medicine, Miami, FL, ²Pediatric Gastroenterology, University of Miami Miller School of Medicine, Miami, FL, ³Miami Transplant Institute, Miami, FL
*Purpose: Invasive fungal disease (IFD) among pediatric solid organ transplant recipients is a relatively rare event, however often results in death. There are many factors…
2020 American Transplant Congress
Assessment of Infectious Complications Following ABO-Blood Group Incompatible Renal Transplant
J. Banbury¹, T. Loosier¹, C. Lin², K. Gutierrez¹
¹University of Alabama at Birmingham Hospital, Birmingham, AL, ²Center for Clinical and Translational Science, University of Alabama at Birmingham, Birmingham, AL
*Purpose: In response to the ongoing organ shortage, ABO-incompatible (ABOi) renal transplant (RT) provides an alternative option for patients with end-stage kidney disease. Literature suggests…
2020 American Transplant Congress
Pre-Liver Transplant Coronary Artery Disease Work-Up for Non-High-Risk Patients
C. Walker¹, M. Hook², T. Matyja², J. Buggs³, E. Rogers³, A. Kumar¹, N. Kemmer⁴
¹Morsani College of Medicine, University of South Florida, Tampa, FL, ²University of Tampa, Tampa, FL, ³Transplant Surgery, Tampa General Hospital, Tampa, FL, ⁴Transplant Hepatology, Tampa General Hospital, Tampa, FL
*Purpose: Coronary artery disease is a leading cause of mortality following orthotopic liver transplant, yet there is not currently a standardized protocol for pre-liver-transplant coronary…
2020 American Transplant Congress
Efficacy Of CMV Prophylaxis In Liver Transplant Recipients
S. LeCorchick, T. Tinkham, N. Oliver, L. Lindberg, L. Dong, J. Krong, R. Gilroy
Intermountain Medical Center, Murray, UT
*Purpose: Human cytomegalovirus (CMV) is a ubiquitous beta herpesvirus present in the human population at rates between 30% and 90%. It can be transmitted via…